John Pulcini, MD
Allergy & Immunology · Greenville, SCNPI 1447285374
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 103 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 10.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $563, 2.4 times the $236 reported in 2019. That places this record below the midpoint for allergy & immunology clinicians in SC, where the typical reported total is $7,297.
Across 103 payments — averaging $20.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$228
- GSK$204
- Pfizer$182
- AstraZeneca$174
- Biocryst US Sales Co., LLC$166
- Sanofi$164
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,147100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 10 | $228 |
| GSK | 11 | $204 |
| Pfizer | 10 | $182 |
| AstraZeneca | 11 | $174 |
| Biocryst US Sales Co., LLC | 6 | $166 |
| Sanofi | 7 | $164 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $148 |
| Amgen | 5 | $109 |
| Novartis | 3 | $82 |
| Pharming Healthcare, Inc. | 4 | $77 |
| Kaleo, Inc. | 4 | $75 |
| Genentech USA, Inc. | 3 | $68 |
| Incyte Corporation | 3 | $65 |
| Grifols USA, LLC | 3 | $56 |
| Hospira, Inc. | 3 | $49 |
| Lilly USA, LLC | 2 | $45 |
| Alk-abello, Inc | 2 | $40 |
| Hikma Pharmaceuticals USA | 2 | $36 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $30 |
| Greer Laboratories, Inc. | 1 | $29 |
| Jubilant Hollisterstier LLC | 1 | $22 |
| GC Biopharma USA, Inc. | 1 | $22 |
| Optinose US, Inc. | 1 | $22 |
| AbbVie | 1 | $22 |
| Shire North American Group Inc | 1 | $18 |
| Vyaire Medical, Inc. | 1 | $12 |
How this compares
$2,147 in reported general payments places this provider in the 20th percentile of 46 allergy & immunology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 97 | $654,001 |
| IcatibantIcatibant Acetate | 22 | $300,265 |
| Dupixent PenDupilumab | 39 | $139,147 |
| Dupixent SyringeDupilumab | 35 | $124,337 |
| XembifyImmune Globulin,gamma(Igg)klhw | 23 | $100,428 |
| XolairOmalizumab | 40 | $97,156 |
| TezspireTezepelumab-Ekko | 18 | $78,979 |
| Zileuton ErZileuton | 12 | $14,161 |
| Epinephrine | 32 | $5,295 |
| Azelastine Hcl | 97 | $1,945 |
| Montelukast Sodium | 94 | $1,053 |
| Ipratropium Bromide | 54 | $973 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 25 | $641 |
| Fluticasone Propionate | 40 | $441 |
| Famotidine | 19 | $224 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| CSL BehringHizentra | $228 | $654,00197 claims |
| Grifols USA, LLCXembify | $56 | $100,42823 claims |
| AstraZenecaTezspire | $174 | $78,97918 claims |
| Hikma Pharmaceuticals USAEpinephrine | $36 | $5,29532 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 46 allergy & immunology providers in South Carolina.
Other allergy & immunology in Greenville
- Douglas JohnstonGreenville$329K
- Reid JohnstoneGreenville$13K
- Rudolph JohnstoneGreenville$10K
- Charles GreeneGreenville$9K
- Andrea LantzGreenville$9K
- James KuhlenGreenville$8K
- Shiven PatelGreenville$7K
- Dennis PaulkGreenville$5K
- Melissa AndersonGreenville$3K
- Erin MullaneyGreenville$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.